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ABSTRACT
Purpose: We describe the use of a hemostatic wax seal-
ant during laparoscopic renal ablative procedures to allow
airtight transabdominal access of the treatment probe
through a standard 5-mm port.
Methods: Following Tru-cut biopsy of the renal mass,
Bone Wax was used to occlude the external opening of an
established 5-mm laparoscopic port. The cryotherapy or
radiofrequency treatment probe was then passed through
the waxy material and inserted appropriately into the
renal lesion while pneumoperitoneal pressure was main-
tained.
Results: In all cases, the Bone Wax provided a sufficient
airtight seal to allow use of the 5-mm port during ablative
therapy of renal masses.
Conclusions: Use of Bone Wax during laparoscopic re-
nal ablative surgery allows the use of an established 5-mm
port, thus obviating a separate skin incision and reducing
the tract-site exposure to the needle probe.
Key Words: Laparoscopy, Renal, Tumor ablation, Radio-
frequency ablation, Bone Wax.
INTRODUCTION
Over the past decade, several probe ablative therapies
have emerged for the treatment of patients with small,
localized renal tumors.1 Cryoablation2 and radiofrequency
ablation (RFA)3 have been studied in the greatest detail
with promising intermediate oncological outcomes. Vari-
ous treatment approaches for the 2 modalities, namely
laparoscopic and percutaneous, are currently practiced.
The decision to choose one approach over another is
related to surgeon preference, tumor location and acces-
sibility (anterior vs posterior), proximity to other abdom-
inal organs, and patient habitus and comorbidities.
During laparoscopic ablative surgery, the thermal probe is
routinely placed through a separate skin incision to access
the renal tumor. Although no case reports of tract-site
recurrences have been noted after probe-ablative
nephron-sparing surgery, a theoretical risk of tract con-
tamination exists. Case reports of tract recurrence for renal
cell carcinoma after laparoscopic nephrectomy have been
reported,4,5 with greater risk noted in morcellated speci-
mens and cases where extraction was done without a
plastic bag.6 To reduce the number of skin incisions and
eliminate tract exposure to the needle probe, we describe
the use of Bone Wax (Tyco/Syneture, Mansfield, MA,
USA) to provide an airtight seal of a 5-mm laparoscopic
port.
METHOD
The technique used for laparoscopic renal ablation (cryo-
therapy and RFA) has previously been described.3,7 The
main steps can be summarized as establishment of trans-
peritoneal or retroperitoneal access, laparoscopic dissec-
tion for tumor exposure, laparoscopic ultrasonography
followed by Tru-cut needle biopsy8 of the renal mass.
Thereafter, Bone Wax was used to completely occlude the
external opening of one of the established 5-mm laparo-
scopic ports (Ethicon Endo-Surgery, Somerville, NJ),
which would provide optimal tumor access (Figure 1).
Placement of either the cryoprobe or the RITA StarBurst
(RITA Medical Systems, Fremont, CA) ablation probe
through the 5-mm port was successful in all patients while
pneumoperitoneal pressure was maintained. Additional
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SCIENTIFIC PAPERBone Wax was applied along the shaft of the probe to
ensure an airtight seal once the thermal-needle was ap-
propriately positioned into the center of the tumor (Fig-
ure 2). Following the treatment cycles, the ablation probe
was withdrawn under laparoscopic guidance into the
5-mm port canal. The 5-mm port and the probe were
removed together from the abdominal wall, thus eliminat-
ing any contact with the skin tract. A new 5-mm port was
repositioned into the surgical space by using the same
skin tract. FloSeal (Baxter International, Deerfield, IL) and
argon beam coagulation were then used to ensure hemo-
stasis before case completion.
RESULTS
We have used the Bone Wax sealant to aid with thermal
probe positioning during laparoscopic ablative proce-
dures. All treatments were successfully performed through
previously established 5-mm laparoscopic ports while
maintaining pneumoperitoneal pressure. A separate skin
puncture was not required, and the ablation probe was
never in contact with subcutaneous tissues of the abdom-
inal wall.
DISCUSSION
Minimally invasive tissue ablative procedures are evolving
into an appropriate treatment option for managing small
and exophytic renal tumors in select patients.8 The lapa-
roscopic approach to these modalities often requires the
placement of the thermal probe through a separate skin
incision to maintain pneumoperitoneal pressure. Al-
though rare, removal of the probe through the skin tract
after lesion treatment may increase the potential for tumor
cell transfer and port-site contamination. Our described
technique using Bone Wax has proved useful in utilizing
an established 5-mm laparoscopic port and avoiding di-
rect contact of the ablation probe with subcutaneous tis-
sues.
Bone Wax is a sterile mixture of beeswax, paraffin, and
isopropyl palmitate, a wax-softening agent. This inexpen-
sive material is often used to achieve local hemostasis of
bone by acting as a mechanical barrier, particularly in
Figure 1. (a) Application of Bone Wax (40 mm x 15 mm) to the outer surface of a standard 5-mm laparoscopic port. (b) The waxy,
malleable material provides an ideal sealant and port-site reducer to allow an airtight entry of the renal ablative probe.
Figure 2. Renal ablative probe positioned appropriately during
the treatment process. Note the additional Bone Wax application
around the port-entry site to ensure airtight closure thus main-
taining pneumoperitoneal pressure.
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not act biochemically and is nonabsorbable. Based on its
physical properties, it can easily be molded into the ex-
ternal canal of a laparoscopic port and can provide suffi-
cient coaptation around the ablation need to ensure an
airtight seal despite pneumoperitoneal pressures of 14
mm Hg to 20 mm Hg.
Despite its merits, this technique has several limitations. In
obese patients, where the abdominal wall may be very
thick, distance to the tumor may be a limiting factor. The
additional 5 cm to 7 cm that may be gained by having the
probe placed directly through the skin rather than through
the laparoscopic port may be important in certain individ-
uals. Furthermore, tumors with larger diameters, irregular
shapes, and patients with multiple tumors may require
placement of several probes to deliver appropriate ther-
apy. As such, the placement of additional 5-mm ports
simply for probe insertion would be inappropriate. In
these laparoscopic cases, where direct, percutaneous in-
sertion is used, we recommend probe activation in the
peritoneal cavity before extraction to eradicate potential
tumor cells.
CONCLUSIONS
Use of Bone Wax is a simple, inexpensive technique to
avoid separate skin incisions while minimizing tract-site
contact with ablation probes.
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